Surgical Innovations Group Plc announced the appointment of Jonathan Glenn as Senior Independent Non-executive Director and Chairman-designate of the Company with immediate effect. Jonathan is an experienced board director and chairman, with an excellent track record in the medical device sector. He is currently Non-executive Chairman of Tissue Regenix plc, and was formerly Group CEO of Consort Medical Plc from 2007 to 2020, where he oversaw the £230 million acquisition of a European contract development and manufacturing organisation.

Jonathan led the business as CEO until its acquisition for £505m in 2020. Jonathan is a member of the Institute of Chartered Accountants in England and Wales. He joins the board in anticipation of the upcoming retirement of Professor Mike McMahon, the founder of the Company, who retires from the board at the Annual General Meeting of the Company expected to take place on 27 June 2023.

Following an orderly handover process, Jonathan will succeed Nigel Rogers as Chairman upon announcement of the interim results expected in September 2023. Nigel has indicated his intention to remain on the board until an additional independent non-executive director has been appointed. Jonathan Martin Glenn (aged54) is currently, or has during the past five years, been a director of the following companies: Current directorships or partnerships: Tissue Regenix Group plc; Tissue Regenix Holdings Limited; TRX Cardiac Limited; TRX Orthopaedics Limited; TRX Vascular Limited; TRX Wound Care Limited; Tissue Regenix Limited; Tissue Regenix Holdings Inc; Tissue Regenix Wound Care Inc; and TRX Orthopedics Inc. Previous directorships or partnerships: AESICA BC Limited; AESICA Formulation Development Limited; AESICA Holdco Limited; AESICA M1 Limited; AESICA M2 Limited; AESICA Queensborough Limited; AESICA Trustee Company Limited; Bespak Europe Limited; Bespak Finance Limited; Bespak Holdings Limited; Binx Health Limited; Consort Medical Finance 2010 Limited; Consort Medical Finance Limited; Consort Medical Limited; Consort Medical plc; Integrated Aluminium Components Limited; Medical House (ASI) Limited; Medical House Products Limited; Pharmaron Manufacturing Services (UK) Ltd; The Medical House Group Limited; and The Medical House Limited.